Sinil Pharmaceutical Co Ltd banner
S

Sinil Pharmaceutical Co Ltd
KOSDAQ:012790

Watchlist Manager
Sinil Pharmaceutical Co Ltd
KOSDAQ:012790
Watchlist
Price: 5 980 KRW -0.33% Market Closed
Market Cap: ₩71.7B

Balance Sheet

Balance Sheet Decomposition
Sinil Pharmaceutical Co Ltd

Balance Sheet
Sinil Pharmaceutical Co Ltd

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
968
1 426
1 078
2 113
2 339
2 805
845
2 258
3 895
4 696
2 434
1 998
2 474
3 298
2 071
538
2 262
1 727
2 975
4 163
7 340
4 944
7 519
4 643
Cash
0
0
0
0
0
0
0
0
0
0
43
91
18
18
38
31
25
32
27
19
30
39
14
22
Cash Equivalents
968
1 426
1 078
2 113
2 339
2 805
845
2 258
3 895
4 696
2 391
1 907
2 456
3 280
2 033
507
2 237
1 695
2 948
4 144
7 310
4 905
7 505
4 621
Short-Term Investments
2 141
739
125
0
0
0
0
500
1 016
4 024
7 600
8 324
10 080
14 730
15 511
13 996
11 017
11 954
10 608
10 430
13 530
18 410
15 900
29 070
Total Receivables
15 293
17 094
19 054
19 379
20 049
18 407
19 913
20 076
19 802
18 763
17 654
16 259
17 295
18 007
18 736
19 957
19 969
19 870
21 969
21 192
20 721
23 713
22 845
20 839
Accounts Receivables
15 007
17 043
19 039
19 351
20 029
18 309
19 803
19 992
19 795
18 545
17 535
16 163
16 977
17 689
18 516
19 638
19 463
19 393
21 704
21 035
20 684
23 577
22 116
20 737
Other Receivables
286
51
15
28
20
98
110
84
7
218
119
96
318
318
220
319
506
477
265
157
37
136
729
101
Inventory
3 328
3 717
4 756
5 263
4 847
5 028
5 762
7 011
7 900
6 824
6 821
6 510
6 086
7 064
8 953
10 665
13 418
13 393
15 072
16 937
16 700
20 188
22 492
22 861
Other Current Assets
92
45
39
20
1 050
1 266
1 940
892
834
122
333
594
203
2 122
559
8 631
971
77
43
49
135
26
31
36
Total Current Assets
21 823
23 022
25 051
26 776
28 285
27 506
28 460
30 736
33 447
34 428
34 841
33 684
36 138
45 221
45 830
53 787
47 637
47 022
50 667
52 772
58 427
67 280
68 787
77 449
PP&E Net
8 018
9 000
9 459
9 400
10 530
10 337
11 787
15 259
15 266
12 684
12 406
15 546
14 957
14 763
17 450
16 982
25 270
24 289
28 005
32 150
30 999
35 744
41 916
44 789
PP&E Gross
8 018
9 000
9 459
9 400
10 530
10 337
11 787
15 259
15 266
0
0
0
0
0
0
0
0
0
0
0
0
0
41 916
44 789
Accumulated Depreciation
3 461
4 045
4 815
5 676
6 437
7 639
8 167
8 678
10 300
0
0
0
0
0
0
0
0
0
0
0
0
0
43 918
48 992
Intangible Assets
0
0
79
79
720
1 115
1 485
1 954
2 105
2 643
3 911
4 257
3 757
4 084
4 333
4 286
1 223
1 155
1 135
1 320
1 801
1 870
1 810
1 736
Note Receivable
0
0
0
25
20
0
0
0
0
19
20
15
14
0
0
240
0
20
250
50
50
50
50
50
Long-Term Investments
599
1 773
2 883
2 919
4 164
5 434
5 518
5 371
5 502
7 516
7 473
7 160
13 702
13 772
17 411
20 549
26 099
31 132
34 828
35 044
34 821
34 833
36 616
38 213
Other Long-Term Assets
395
928
1 015
1 240
728
913
1 362
1 655
1 849
2 267
2 052
1 947
2 041
2 066
2 241
2 210
2 292
2 787
2 953
3 473
2 876
3 055
3 280
3 624
Total Assets
30 835
N/A
34 723
+13%
38 487
+11%
40 438
+5%
44 447
+10%
45 305
+2%
48 611
+7%
54 976
+13%
58 170
+6%
59 557
+2%
60 703
+2%
62 609
+3%
70 609
+13%
79 906
+13%
87 264
+9%
98 053
+12%
102 521
+5%
106 404
+4%
117 838
+11%
124 810
+6%
128 974
+3%
142 832
+11%
152 460
+7%
165 861
+9%
Liabilities
Accounts Payable
493
643
513
750
590
617
1 223
1 041
1 143
1 417
1 564
2 511
3 027
2 836
2 370
1 952
3 463
2 762
4 044
3 756
4 967
6 807
5 455
5 356
Accrued Liabilities
309
341
455
435
457
521
480
634
528
458
583
601
671
821
858
658
974
836
2 140
1 557
1 436
1 361
2 154
1 639
Short-Term Debt
2 984
3 424
3 340
2 159
1 535
1 548
1 029
629
628
1 000
1 055
926
858
741
546
378
311
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
522
518
517
317
317
125
241
210
543
543
543
11
0
0
0
0
0
0
123
126
134
136
165
164
Other Current Liabilities
976
1 892
2 052
2 427
2 995
2 574
2 772
3 530
4 124
2 506
2 192
3 307
3 544
3 804
3 243
4 390
3 521
3 805
4 771
4 947
5 487
7 656
6 371
9 294
Total Current Liabilities
5 284
6 819
6 878
6 088
5 894
5 385
5 744
6 043
6 967
5 925
5 938
7 356
8 101
8 202
7 016
7 378
8 269
7 403
11 078
10 387
12 023
15 959
14 145
16 453
Long-Term Debt
1 419
1 210
992
675
1 132
715
474
3 265
2 721
2 178
1 635
0
0
0
0
0
0
0
393
267
139
4
379
268
Deferred Income Tax
183
0
0
0
80
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
1 889
1 377
1 638
1 809
1 990
1 987
2 498
3 021
2 509
1 877
1 226
191
336
853
2 074
3 485
3 321
3 816
5 122
6 672
3 615
3 591
3 041
2 635
Total Liabilities
8 776
N/A
9 406
+7%
9 508
+1%
8 572
-10%
9 096
+6%
8 086
-11%
8 716
+8%
12 329
+41%
12 197
-1%
9 980
-18%
8 799
-12%
7 547
-14%
8 437
+12%
9 055
+7%
9 091
+0%
10 863
+19%
11 590
+7%
11 219
-3%
16 593
+48%
17 326
+4%
15 777
-9%
19 554
+24%
17 565
-10%
19 356
+10%
Equity
Common Stock
3 950
3 950
3 950
3 950
3 950
3 950
3 950
3 950
3 950
3 950
3 950
3 950
3 950
3 950
3 950
3 950
3 950
3 950
3 950
5 451
5 609
5 771
5 993
5 993
Retained Earnings
15 510
18 767
22 434
25 291
28 549
30 678
33 416
36 292
39 518
43 071
45 977
48 535
55 663
64 371
71 623
80 640
84 381
88 635
94 695
100 940
106 663
117 118
128 688
140 444
Additional Paid In Capital
3 605
3 605
3 605
3 605
3 605
3 605
3 605
3 605
3 605
3 605
3 605
2 671
2 671
2 671
3 605
3 605
3 605
3 605
3 605
2 104
2 104
2 104
2 104
2 104
Unrealized Security Profit/Loss
0
0
6
24
252
10
70
195
95
45
605
912
894
865
0
0
0
0
0
0
0
431
532
677
Treasury Stock
1 005
1 005
1 005
1 005
1 005
1 005
1 005
1 005
1 005
1 005
1 005
1 005
1 005
1 005
1 005
1 005
1 005
1 005
1 005
1 012
1 180
1 285
1 358
1 358
Other Equity
0
0
0
0
0
0
0
0
0
0
17
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Equity
22 060
N/A
25 317
+15%
28 978
+14%
31 865
+10%
35 351
+11%
37 218
+5%
39 895
+7%
42 647
+7%
45 973
+8%
49 576
+8%
51 904
+5%
55 062
+6%
62 172
+13%
70 851
+14%
78 173
+10%
87 190
+12%
90 931
+4%
95 185
+5%
101 245
+6%
107 484
+6%
113 196
+5%
123 277
+9%
134 895
+9%
146 506
+9%
Total Liabilities & Equity
30 835
N/A
34 723
+13%
38 487
+11%
40 438
+5%
44 447
+10%
45 305
+2%
48 611
+7%
54 976
+13%
58 170
+6%
59 557
+2%
60 703
+2%
62 609
+3%
70 609
+13%
79 906
+13%
87 264
+9%
98 053
+12%
102 521
+5%
106 404
+4%
117 838
+11%
124 810
+6%
128 974
+3%
142 832
+11%
152 460
+7%
165 861
+9%
Shares Outstanding
Common Shares Outstanding
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
12
12